While IL-4 has been proposed to be the primary activator of pro-tumoural TAMs such as the “M2” phenotype (60), it also has some anti-tumour effects thought to be related to the maturation of myeloid precursor cells (61). This evidence concerns the gene IL4 and neoplasm.